Oncology R&D - Salubris Bio

One in three people will be diagnosed with cancer in their lifetime

Cancer is the second leading cause of death in the U.S., after heart disease

In 2021, there were an estimated 1,898,160 new cancer cases diagnosed and 608,570 cancer deaths in the U.S.

Oncology R&D

Immunotherapy is a promising and evolving treatment for cancer that helps harness the body’s own immune system to target and kill cancer cells. However, not everyone responds to treatment and some immunotherapies are associated with severe side effects.

SalubrisBio is currently developing a potential treatment to make immunotherapies more effective and less toxic. Check back for updates on our first oncology clinical trial planned for 2022.

Oncology statistics

One in three people will be diagnosed with cancer in their lifetime¹

Cancer is the second leading cause of death in the U.S., after heart disease²

In 2021, there were an estimated 1,898,160 new cancer cases diagnosed and 608,570 cancer deaths in the U.S.³

1 https://www.cancer.org/

2 https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

3 https://seer.cancer.gov/statfacts/html/all.html